MDMA, the main ingredient of the party drug ecstasy, could help reduce symptoms among those living with post-traumatic stress disorder, research suggests. Now scientists have released the latest of several small studies showing that MDMA, when combined with talking therapies, could prove effective in reducing symptoms. Indeed, six of the seven participants assigned to take 75mg of the drug and seven of the 12 given 125mg no longer met the criteria for PTSD, compared with two of the seven participants given the 30mg dose. The team say benefits persisted 12 months after the study began, with 16 of the 24 participants who completed the study no longer meeting the criteria for PTSD, among other improvements. “It could revolutionise the treatment of PTSD, for which there has been almost no progress in the past 20 years,” he said.

Source: The Guardian May 01, 2018 22:30 UTC